Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Tremfya Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. Tremfya is the first and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results